Patient Guide: A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 36 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05630183
Status: ACTIVE_NOT_RECRUITING
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Phase: PHASE2

Where You Can Participate

This study is available at 36 locations across the country.

Top locations include:
  • • Scottsdale, Arizona
  • • Los Angeles, California
  • • Newport Beach, California
  • • And 33 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer - Join Clinical Trial NCTNCT05630183

How to Join This Clinical Trial - NCTNCT05630183

Learn how to participate in this PHASE2 trial studying an investigational therapy for Metastatic Pancreatic Ductal Adenocarcinoma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Metastatic Pancreatic Ductal Adenocarcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Metastatic Pancreatic Ductal Adenocarcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05630183 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 36 locations. Find a study site near you:

Clinical Research Site

Scottsdale, Arizona 85258 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90033 - United States

Status: Contact for availability

Clinical Research Site

Newport Beach, California 92663 - United States

Status: Contact for availability

Clinical Research Site

Santa Monica, California 90404 - United States

Status: Contact for availability

Clinical Research Site

Newark, Delaware 19713 - United States

Status: Contact for availability

Clinical Research Site

Fort Myers, Florida 33901 - United States

Status: Contact for availability

Clinical Research Site

Palm Bay, Florida 32909 - United States

Status: Contact for availability

Clinical Research Site

Saint Petersburg, Florida 22705 - United States

Status: Contact for availability

Clinical Research Site

Arlington Heights, Illinois 60005 - United States

Status: Contact for availability

Clinical Research Site

Columbia, Maryland 21044 - United States

Status: Contact for availability

And 26 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Metastatic Pancreatic Ductal Adenocarcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships